Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR (JHPCY)
About Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
JIANGSU HENGRUI PHARM CO
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Dividend yield
- 0.48%
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR (JHPCY) Stock Price
- Trading 39% below its 52-week high.
- Pays a dividend yielding about 0.48% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR.
Write a review
News about Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
News & sentiment via Polygon.io
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR: frequently asked questions
Is Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR an American company?
No — Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR is not an American company. Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR is incorporated in China. It maintains US operations and its shares trade on OTC — which is why it is often mistaken for a US company.
Where is Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR incorporated?
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR is legally incorporated in China, according to its GLEIF legal-entity record.
Is Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR traded on a US stock exchange?
Yes — Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR trades under the ticker JHPCY on the OTC. A US stock listing does not by itself make a company American — incorporation and ownership are what this page reports.
Is Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR publicly traded?
Yes — Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR is a publicly traded company. Its stock trades under the ticker symbol JHPCY on the OTC.